29 August
2024
Assura plc
Notice of
Dividend
Assura plc ("Assura" or "the
Company"), the specialist healthcare property
investor and developer, today announces that the
next quarterly interim dividend of 0.84 pence per
share will be paid on 9 October 2024 to shareholders on the
register on 6 September 2024 (the "Record Date"). The Ex-dividend
Date will be 5 September 2024.
This interim dividend will be wholly Property Income
Distribution ("PID"). Forms to register for gross PIDs are
available on the Company's website and must be returned to the
Company registrars, Link Group at Central Square, 29 Wellington
Street, Leeds, LS1 4DL to arrive by 4.30pm on 27 September 2024.
Please refer to Company's
website
HERE for more
information.
Shareholders may choose for the
dividend to be paid either as cash or to be settled in New Shares
via the Scrip Dividend Alternative. The Scrip Dividend Alternative
price is to be calculated using the average of the middle market
quotations for an Ordinary Share, as derived from the Daily
Official List of the London Stock Exchange, for the five
consecutive business days commencing on the Ex-dividend Date and
will be announced by the Company and detailed on the Company's
website on 12 September 2024.
Any shareholders wishing to take up
the Scrip Dividend Alternative, who have not already done so, will
have until 4.30pm on 27 September 2024 either to return their
completed mandate form to the Company registrars, Link Group at
Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case
of shareholdings in certificated form) or to take the necessary
action via the CREST system (in the case of shareholdings in
uncertificated form).
The Circular concerning this Scrip
Dividend Alternative is available on the Company's
website, www.assuraplc.com
and is also available for inspection at the
National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
- Ends
-
For more information, please
contact:
|
Assura plc
David Purcell, Investor Relations
Director
|
Tel: 0161 515 2043
Email: Investor@assura.co.uk
|
|
FGS
Global
Gordon Simpson
Grace Whelan
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
specialist healthcare property investor and developer. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura we BUILD for health and as
the first FTSE 250 certified B Corp we are committed to keeping ESG
at the heart of our strategy, creating Healthy Environments (E) and
Healthy Communities (S) and maintaining a Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a registered trademark of
the European Public Real Estate Association.
